Endothelin-converting enzyme-like 1 (ECEL1) is a member of the M13 family of neutral endopeptidases which play an essential role in the neural regulation of vertebrate respiration. Genetic deficiency of this protein results in respiratory failure soon after birth. Comparative ECEL1 amino acid sequences and structures and ECEL1 gene locations were examined using data from several vertebrate genome projects. Vertebrate ECEL1 sequences shared 66%-99% identity as compared with 30%-63% sequence identities with other M13like family members, ECE1, ECE2, and NEP (neprilysin or MME). Three N-glycosylation sites were conserved among most vertebrate ECEL1 proteins examined. Sequence alignments, conserved key amino acid residues, and predicted secondary and tertiary structures were also studied, including cytoplasmic, transmembrane, and luminal sequences and active site residues. Vertebrate ECEL1 genes usually contained 18 exons and 17 coding exons on the negative strand. Exons 1 and 2 of the human ECEL1 gene contained 5′-untranslated (5′-UTR) regions, a large CpG island (CpG256), and several transcription factor binding sites which may contribute to the high levels of gene expression previously reported in neural tissues. Phylogenetic analyses examined the relationships and potential evolutionary origins of the vertebrate ECEL1 gene with six other vertebrate neutral endopeptidase M13 family genes. These suggested that ECEL1 originated in an ancestral vertebrate genome from a duplication event in an ancestral neutral endopeptidase M13-like gene.
Introduction
Endothelin-converting enzyme L1 (ECEL1, also called Xce protein; EC 3.4.24.-) is one of at least seven members of the M13 family of neutral endopeptidases which are zinc-containing type II transmembrane enzymes. [1] [2] [3] Neprilysin (also called atriopeptidase, common acute lymphocyte antigen, and enkephalinase; EC 3.4.24.11) is the best characterized M13 family member, and participates in the inactivation of signaling peptides involved in regulating blood pressure, neuronal activity, and the immune system. [4] [5] [6] Endothelin-converting enzyme 1 (ECE1; EC 3.4.24.71) and endothelinconverting enzyme 2 (ECE2; EC 3.4.24.71) are related M13 family members, 7-10 which play a role in the processing of regulatory peptides in the body, although ECE2 also encodes a methyltransferase domain. 11 The gene encoding ECEL1 (ECEL1 in humans; Ecel1 in mice) is expressed at very high levels in the central nervous system, sympathetic ganglia, uterine subepithelial cells, and in the primordia of the stratium, hypothalamus, and cranial motor nuclei. 12, 13 ECEL1 gene expression is also induced in response to various forms of brain injury, although this induction is restricted to neurons. 13, 14 This neuronal damage induction feature for mammalian ECEL1 has led to another name for this gene, ie, DINE or damage-induced neuronal endopeptidase, 15 which is regulated by leukemia inhibitory factor and other transcription factors. 14, 16 The upregulation of ECEL1 following neural damage has provided an insight into the mechanism of protection against neuronal death by the activation of antioxidant enzymes, such as Cu/Zn superoxide dismutase, Mn superoxide dismutase, and glutathione peroxidase through the proteolytic activity of ECEL1. 13, 16 Moreover, high expression of ECEL1 is associated with a favorable prognosis in human neuroblastomas. 17 Studies of Ecel1 -/Ecel1knockout mice have shown that ECEL1 deficiency causes neonatal lethality as a result of respiratory failure soon after birth, even though there were no abnormalities in organs and tissues or pulmonary surfactant proteins. [18] [19] [20] Consequently, these studies have suggested that ECEL1 performs an essential role in the nervous control of respiration, although the natural substrate for ECEL1 has not been described. Structures of three mammalian ECEL1 genes have been examined, including in man, rat, and mouse, and shown to contain 18 exons of DNA encoding ECEL1 sequences, which undergo exon shuffling, generating isoproteins in each case. 15, 21, 22 This paper reports the predicted gene structures and amino acid sequences for several vertebrate ECEL1 genes and proteins, the predicted structures for vertebrate ECEL1 proteins, a number of potential sites for regulating human ECEL1 gene expression, and the structural, phylogenetic, and evolutionary relationships for these genes and enzymes with those for six other vertebrate M13 neutral endopeptidase gene families.
Materials and methods
Vertebrate ECEL1 gene and protein identification BLAST (Basic Local Alignment Search Tool) studies were undertaken using web tools from the National Center for Biotechnology Information (NCBI). 23, 24 Protein BLAST analyses used vertebrate ECEL1, ECE1, and ECE2 amino acid sequences described previously (Table 1) . 12, 21, 25 Nonredundant protein sequence databases for several mammalian genomes were examined using the BLASTP algorithm, including human (Homo sapiens), gorilla (Gorilla gorilla), orang-utan (Pongo abelii), marmoset (Callithrix jacchus), cow (Bos taurus), mouse (Mus musculus), rat (Rattus norvegicus), guinea pig (Cavia porcellus), pig (Sus scrofa), dog (Canis familiaris), opossum (Monodelphis domestica), chicken (Gallus gallus), lizard (Anolis carolinensis), frog (Xenopus tropicalis and Xenopus laevis), puffer fish (Tetraodon nigroviridis, Fugu rubripes), and zebrafish (Danio rerio). 26 This procedure produced multiple BLAST "hits" for each of the protein databases which were individually examined and retained in FASTA format, and a record kept of the sequences for predicted mRNAs and encoded ECE-like proteins. These records were derived from annotated genomic sequences using the gene prediction method, ie, GNOMON and predicted sequences with high similarity scores for human ECEL1, ECE1, and ECE2. Predicted ECE-like protein sequences were obtained in each case and subjected to analyses of predicted protein and gene structures.
BLAT analyses were undertaken subsequently for each of the predicted ECEL1, ECE1, ECE2, KELL, NEP, NEPL1, and PHEX amino acid sequences using the UC Santa Cruz Genome Browser with the default settings to obtain the predicted locations for each of the vertebrate ECEL1 genes, including predicted exon boundary locations and gene sizes. 27 BLAT analyses were similarly undertaken for other vertebrate ECE-like genes using previously reported sequences in each case (see Table 1 and Supplementary Table 1 ). Structures for human and mouse isoforms (splicing variants) were obtained using the AceView website to examine predicted gene and protein structures. 22 
Predicted structures and properties of vertebrate ECEL1
Predicted secondary and tertiary structures for human and other vertebrate ECEL1, ECE1, and ECE2 proteins were obtained using the Swiss-Model web server with the reported tertiary structure for human ECE1 complexed with phosphoramidon (PDB:3dwbA) serving as the template in each case. 28, 30 The following modeled residue ranges were observed: 103-775 for human ECEL1; 96-763 for chicken ECEL1; 101-770 for human ECE1; and 162-883 for human ECE2 (which excludes the methyltransferase region). Predicted secondary structures for human and mouse N-terminal regions of ECEL1 (residues 2-60), ECE1 (residues 2-68), and ECE2 (residues 2-178, including the methyltransferase domain) excluded from the Swiss-Model analyses, were obtained using PSIPRED prediction web tools (http://bioinf.cs.ucl.ac.uk/psipred/). 30 Molecular weights, N-glycosylation sites, and predicted transmembrane, cytosolic, and luminal sequences for vertebrate ECEL1, ECE1, and ECE2 proteins were obtained using Expasy web tools (http://au.expasy.org/tools/pi_tool.html). 31 The identification of conserved domains for ECEL1 was conducted using NCBI web tools (http://www.ncbi.nlm.nih.gov/Structure/ cdd/wrpsb.cgi). 32 Comparative human (ECEL1) and mouse (Ecel1) gene expression
The genome browser (http://genome.ucsc.edu) was used to examine GNF Expression Atlas 2 data using various expression chips for human and mouse ECEL1 genes (http://biogps. gnf.org). 33 Gene array expression "heat maps" were examined for comparative gene expression levels among human and mouse tissues showing high (red), intermediate (black), and low (green) expression levels.
Phylogeny studies and sequence divergence
Phylogenetic analyses were undertaken using the http:// phylogeny.fr platform. 34 Alignments of vertebrate ECEL1 sequences, six other vertebrate M13 neutral endopeptidase sequences, and two nematode (Caenorhabditis elegans) neprilysin-like (NEP) sequences were assembled using PMUSCLE (Table 1) . 35 Ambiguous alignment regions, including the methyltransferase region of ECE2, were excluded prior to phylogenetic analysis, yielding alignments for comparisons of vertebrate ECEL1 sequences with vertebrate neutral endopeptidase and nematode (C. elegans) M13-like sequences. The phylogenetic tree was constructed using the maximum likelihood tree estimation program, PHYML. 36, 37 
Results and Discussion

Alignments of vertebrate ECEL1 amino acid sequences
The deduced amino acid sequences for pig (S. scrofa), chicken (G. gallus), and frog (X. tropicalis) ECEL1 are shown in Figure 1 , together with previously reported sequences for man and mouse ECEL1 (Table 1) . 12, 21 Alignments of human with other vertebrate ECEL1 sequences examined were 66%-99% identical, suggesting that these are products of the same family of genes, whereas comparisons of sequence identities for vertebrate ECEL1 proteins with human ECE1 and ECE2 proteins exhibited lower levels of sequence identities (34%-37% and 30%-37% respectively), indicating that these are members of distinct ECE-like gene families ( Table 1) .
The amino acid sequences for vertebrate ECEL1 proteins contained between 763 (for chicken ECEL1) and 785 (for puffer fish [F. rubripes] ECEL1) residues whereas most mammalian ECEL1 sequences contained 775 amino acids ( Figure 1 and Table 1 ). Previous studies have reported several key regions and residues for human and mouse ECEL1 proteins (human ECEL1 amino acid residues were identified in each case). These included an N-terminus cytoplasmic tail (58 residues excluding the N-terminus methionine) followed by a hydrophobic transmembrane 23-residue segment which may anchor the enzyme to the plasma membrane and the endoplasmic reticulum. 12, 25 A comparison of 16 vertebrate ECEL1 sequences for these N-terminal regions revealed a high degree of conservation, especially for residues 5-23, which were substantially invariant among all vertebrate sequences examined (see Figures 1 and 2) , yielding the following conserved sequence: Tyr-Ser-Leu/ Met-Thr-Ala-His-Tyr-Asp-Glu-Phe-Gln-Glu-Val-Lys-Tyr-Val-Ser-Arg/Lys-Cys/Tyr. The biochemical role for this conserved N-terminal cytoplasmic tail sequence remains to be determined. A variable sequence region containing multiple glycine residues (residues 24-51 for human ECEL1) was followed by a predicted transmembrane spanning segment (human ECEL1 residues 60-82), which was predominantly invariant among the 16 vertebrate ECEL1 sequences examined. This transmembrane region was further characterized by conserved "book-end" sequences as Arg60-Arg61-Glu62 at the N-terminal end and Lys86-Tyr78-Leu79 at the C-terminal end of the membrane anchoring segment, which may contribute to the membrane spanning properties reported. 12, 25 Residues 83-775 of the human ECEL1 sequence were identified using bioinformatics as a large peptidase family M13 neprilysin-like domain which is involved in proteolysis of neuroactive peptides in the body. 32 This C-terminal region is predicted to be localized in the luminal zone of the endoplasmic reticulum and to contain an active M13-like peptidase capable of metabolizing physiologically active peptides. Three N-glycosylation sites were consistently found for these vertebrate ECEL1 peptidase sequences, namely Asn255-Ser256-Ser257, Asn322-Ile323-Thr324n, and Asn656-Phe657-Thr658 ( Figure 1 ). In addition, 11 conserved active site residues were observed for these vertebrate ECEL1 sequences, deduced from the M13 peptidase domain active site residues reported from NCBI domain studies. 32 These included an active site catalytic residue (Glu613); three residues involved in binding the active site, zinc (His612, His616, and Glu672), deduced from threedimensional studies of the related enzymes, neprilysin and ECE1, 6, 29 and seven other active site residues, also deduced from the neprilysin and ECE1 tertiary structures, namely submit your manuscript | www.dovepress.com Asn571, Ala572, Ile609, Phe715, Ala716, His737, and Arg743 (Figures 1 and 2 ). Most of the other residues in the active site and C-terminal ECEL1 regions were also predominantly conserved among all of the vertebrate ECEL1 enzymes examined, reflecting strong functional roles for these sequences.
Dovepress
Predicted secondary and tertiary structures for vertebrate ECEL1
Predicted secondary structures for mammalian, chicken, and frog ECEL1 sequences were examined, particularly for the luminal sequences ( Figure 1 ), using the known structure reported for an M13 family peptidase, human ECE1. 29 The α-helix and β-sheet structures were identical in each case, with 31 α-helices and 12 β-sheet structures being observed. Of particular interest were α-helices 24 and 27, which contained the predicted active site residues for human ECEL1, and the β1-sheet in the conserved cytoplasmic N-terminus sequence, the only secondary structure predicted for this region. Predicted tertiary structures for human and chicken ECEL1 are shown in Figure 3 , together with human ECE1 and the predicted structure for the M13 peptidase domain for human ECE2. 29 The tertiary structure of the extracellular domain (residues 90-770) for human ECE1 (with the metalloprotease inhibitor phosphoramidon) is also similar to that described for human neprilysin (NEP) as well as the predicted structures for human and chicken ECEL1. 6 Thirty-one α-helices and 12 β-sheet structures have been described for both M13-like metallopeptidases (ECE1 and NEP), which were also observed for the predicted structures of human and chicken ECEL1. In addition, two major domains for these enzymes were observed, that enclose a large cavity previously shown to contain the active site of the enzyme.
The N-terminal of these two domains has been shown to have a fold similar to that of thermolysin and contains the active site residue, whereas the other domain may serve to control access of substrates to the active site. 29 Overall, the predicted human and chicken ECEL1 structures closely resemble that reported for human ECE1.
Alignments of human and mouse ECEL1, ECE1, and ECE2 amino acid sequences
The amino acid sequences for human and mouse ECEL1, ECE1, and ECE2 (see Table 1 ) are aligned in Figure 4 . For personal use only.
Figure 1
Amino acid sequence alignments for vertebrate ECEL1 sequences. Notes: See Table 1 for sources of ECEL1 sequences; *shows identical residues for ECEL1 subunits; similar alternate residues; dissimilar alternate residues; predicted transmembrane residues are shown in blue; N-glycosylated and potential N-glycosylated Asn sites are in green and #; the endopeptidase active site Glu612 (human ECEL1) is shown in pink; other active site residues are shown in khaki and ^; three predicted zinc-binding residues are shown in blue; predicted α-helices for vertebrate ECEL1 are in shaded yellow and numbered in sequence from the start of the predicted transmembrane domain; predicted β-sheets are in shaded gray and also numbered in sequence from the N-terminus; bold underlined font shows residues corresponding to known or predicted exon start sites; exon numbers refer to human ECEL1 gene exons; note the three major domains identified as cytoplasmic (N-terminal tail); transmembrane (for linking ECEL1 to the endoplasmic reticulum); and luminal regions (C-terminal tail localized in the lumen of the endoplasmic reticulum).
The sequences were 32%-54% identical and showed similarities in several key features and residues, including cytoplasmic N-terminal residues; transmembrane helical regions; predicted N-glycosylation sites for human and mouse ECEL1 (three sites), ECE1 (nine sites), and ECE2 (nine sites), of which one is shared between these sequences (human ECEL1 Asn322-Ile323-Thr324); and similar secondary structures previously identified for human ECE1 (Figures 1 and 3) observed also for ECEL1 and ECE2. 8 The methyltransferase domain previously reported for ECE2 was not observed for the other ECE-like sequences examined, ie, ECE1, ECEL1, and neprilysin. 11 In addition, the Cys428 residue previously identified as forming an interchain disulfide bond for human ECE1 was shared with human and mouse ECE2 sequences but not with ECEL1 sequences. Moreover, the residues previously identified for human ECE1, which are involved in signaling networks (phosphorylated 25Thr and 34Ser), were unique to ECE1 sequences. 38, 39 Active site and zinc-binding residues previously identified for human ECE1 8 were identical in each case for the human and mouse ECEL1 and ECE2 sequences, with the exception of a conservative amino acid substitution observed for the human ECE1 active site residue (Val606Ile) on the corresponding ECEL1 residue. These results suggest that human and mouse ECEL1, ECE1, and ECE2 enzymes share several important properties, features, and conserved residues, including being membranebound with cytoplasmic and transmembrane regions, and have similar secondary structures, but are sufficiently different to serve distinct functions.
Gene locations, exonic structures, and regulatory sequences for vertebrate ECEL1 genes For personal use only. and mouse ECEL1 and the predicted sequences for other vertebrate ECEL1 enzymes and the UC Santa Cruz genome browser. 19, 21, 27 The predicted vertebrate ECEL1 genes were predominantly transcribed on the negative strand, with the exception of guinea pig (C. porcellus), lizard (A. carolensis), and frog (X. tropicalis) ECEL1 genes, which were transcribed on the positive strand. Figure 1 summarizes the predicted exonic start sites for human, mouse, pig, chicken, and frog ECEL1 genes, with each having 17 coding exons in identical or similar positions to those predicted for the human ECEL1 gene. Figure 5 shows the predicted structure for the human ECEL1 gene and exons with an extended CpG island (CpG256) and several transcription factor binding sites, located at the 5′ end of the gene, which is consistent with potential roles in regulating the transcription of this gene and forming part of the ECEL1 gene promoter. The human ECEL1 gene contained 18 exons, with exons 1 and 2 containing the 5′-untranslated (UTR) exon, and the 18th exon containing the translation stop site and the 3′-untranslated region (UTR). The human ECEL1 genome sequence contained several predicted transcription factor binding sites (Supplementary Table 2 ) and a large CpG island (CpG256) located in the 5′-untranslated promoter region in exons 1 and 2 of human ECEL1 on chromosome 2. CpG256 contained 2696 bps with a C plus G count of 1669 bps, a C or G content of 62%, and showed a ratio of observed to expected CpG of 0.92 (Supplementary Table 3 ). Comparative studies of CpG islands for other vertebrate ECEL1 genes show that these are consistently found in the 5′-ECEL1 promoters of varying CpG genome sizes, ranging from 306 in the lizard (A. carolensis) ECEL1 gene to 2999 bps in the dog (C. familiaris) ECEL1 gene ( Supplementary Table 3 ). Therefore, it is likely that the ECEL1 CpG island plays a key role in regulating this gene throughout vertebrate evolution, and may contribute to the very high level of gene expression observed in neural tissues ( Supplementary Figure 1) . 33, 40 The ECEL1 gene has also been identified as one of eight hypermethylation gene targets in a Chinese population. 41 At least 10 transcription factor binding sites were colocated with CpG256 in the human ECEL1 promoter region, which may also contribute to the neural tissue-specific expression (Supplementary Table 2 ). Of special interest among these identified ECEL1 transcription factor binding sites are T-cell leukemia homeobox protein 2 which is required for the development of the enteric nervous system, 42 paired box protein Pax-2 which plays a critical role in the development of the central nervous system, 43 transcription factor E2alpha which is involved as an initiator of neuronal differentiation, 44 STAT5 which functions in signal transduction and activation of transcription, 45 and HMX1 which is a transcription factor involved in development of the hypothalamus. 46 It is also relevant to report that the ECEL1 gene is localized in a region of human chromosome 2 associated with QTL19 (COPD19_H) for chronic obstructive pulmonary disease and an OMIM disease phenotype associated with pulmonary disease, as shown in Figure 5 (http://genome.ucsc. edu). 47 In addition, Kiryu-Seo et al have reported that ECEL1 (or DINE) is synergistically regulated by other transcriptional regulatory regions in the gene promoter of injured neurons, 16 including ATF3, c-Jun, and STAT3. It would appear that the ECEL1 gene promoter is well endowed with gene regulatory sequences, including a large CpG island (CpG256) and several transcription factor binding sites which may contribute to the high levels of expression in mammalian neural tissues and to the response of neuronal cells following injury. In terms of genetic variability of ECEL1 in human populations, recent studies have shown that this gene has 187 annotated single nucleotide polymorphisms, of which 41 are not synonymous, including four which occur in frequencies greater than 1% submit your manuscript | www.dovepress.com
Dovepress
8
Holmes and Cox
Research and Reports in Biochemistry downloaded from https://www.dovepress.com/ by 54.70. 40.11 on 24-Dec-2018 For personal use only.
Figure 4
Amino acid sequence alignments for human and mouse ECEL1, ECE1, and ECE2 sequences. Notes: See Table 1 for sources of human and mouse ECEL1, ECE1, and ECE2 sequences; *shows identical residues for ECE-like subunits; : shows similar alternate residues; . shows dissimilar alternate residues; the predicted methyltransferase domain for ECE2 is shown in red; predicted transmembrane residues are shown in blue; N-glycosylated and potential N-glycosylated Asn sites are in green; signal-phosphorylation sites for human and mouse ECE1 are shown in pink; for active site residues, the catalytic Glu is shown in *, zinc binding residues in * and other active site residues in * or :; active site residues for the methyltransferase domain for ECE2 are shown as ^; active site residues for the luminal ECE-like peptidase domain are shown as ^; predicted α-helices for vertebrate ECE-like sequences and for the ECE2 methyltransferase domain are in shaded yellow and numbered in sequence from the start of the predicted luminal ECE-like domain; predicted β-sheets are in shaded gray and also numbered in sequence for human ECEL1; ECE1 and ECE2 Cys residues involved in inter-subunit -S-S-shown as C; bold underlined font shows residues corresponding to known or predicted exon start sites.
( Figure 5 ). In particular, rs36038969 results in a Lys  Glu substitution within exon 14, a phylogenetically invariant region localized near the ECEL1 active site (Figure 1) , which suggests functional variance for this enzyme within human populations. Even though there is a large number of single nucleotide polymorphisms in this gene, there are no single nucleotide polymorphisms in the 5′-UTR region or the conserved transcription factor binding sites, suggesting that expression of this gene is tightly regulated, which is consistent with evolutionary conservation of these regulatory regions.
Comparative human ECEL1 and mouse Ecel1 tissue expression
Supplementary Figure 1 contains "heat maps" showing comparative gene expression for various human and mouse tissues obtained from GNF Expression Atlas Data using GNF1H (human) and GNF1M (mouse) chips (http://genome. ucsc.edu; http://biogps.gnf.org). 33 These data support a high level of neural tissue expression for human ECEL1 and mouse Ecel1, particularly for neural tissues, which is consistent with previous reports for these genes. 12, 13 Overall, human ECEL1 and mouse Ecel1 tissue expression levels were 0.4-0.7 times submit your manuscript | www.dovepress.com
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Evolution of vertebrate ECEL1 and comparative studies Gene structure and organization for the human ECEL1 gene. Notes: Derived from the AceView website http://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/; shown with capped 5′-ends and 3′-ends for the predicted mRNA sequences; 22 NM refers to the NCBI reference sequence; exons are in pink; the direction for transcription is shown as 5′3′; the solid blue line shows a large CpG256 island at or near the gene promoter; predicted transcription factor binding sites for human ECEL1 are shown; see Supplementary Table 2 for details. The human genome browser (http://genome.ucsc.edu/) was used to identify a disease phenotype in the vicinity of the ECEL1 region: QTL19 (based on RGD 1331635: COPD19_H; chronic obstructive pulmonary disease); 47 as well as single nucleotide polymorphisms for the human ECEL1 gene. Individual nonsynonymous single nucleotide polymorphisms with variant allelic frequencies # 1% in the population were identified (dbSNP 135). The variant nucleotide is underlined. Notes: The tree is labeled with the ECE-like name, and the name of the animal and is "rooted" with the worm (Caenorhabditis elegans) NEP2 and NEP22 sequences, which were used to "root" the tree. Note the seven major clusters corresponding to the ECEL1, ECE1, ECE2, KELL, PHEX, NEP, and NEPL1 gene families. A genetic distance scale is shown. The number of times a clade (sequences common to a node or branch) occurred in the bootstrap replicates is shown. Replicate values of 0.9 (90/100) or more are highly significant with 100 bootstrap replicates performed in each case. A proposed sequence of gene duplication events is shown arising from an ancestral invertebrate ECE-like gene. the average level of gene expression, supporting a key role for this enzyme as an endopeptidase, especially in nerve cells, the hypothalamus, sympathetic ganglion and pituitary gland, and in the neural regulation of respiration (http://www.ncbi. nlm.nih.gov/IEB/Research/Acembly/). 12, 13, 22 Phylogeny and divergence of ECEL1 and other vertebrate ECE-like sequences A phylogenetic tree ( Figure 6 ) was calculated by the progressive alignment of 17 vertebrate ECEL1 amino acid sequences with several vertebrate ECE1 and ECE2 sequences, which was "rooted" with the worm (C. elegans) neprilysin (NEP2 and NEP22) sequences (see Table 1 ). The phylogram showed clustering of the ECEL1 sequences into groups, which was consistent with their evolutionary relatedness as well as groups for vertebrate ECE1, ECE2, KELL, PHEX, NEP, and NEPL1 sequences which were distinct from the worm NEP2 and NEP22 sequences. These groups were significantly different from each other (with bootstrap values . 90/100). It is apparent from this study of vertebrate ECE-like genes and proteins that this is an ancient protein for which a proposed common ancestor for the ECEL1, ECE1, ECE2, KELL, PHEX, NEP, and NEPL1 genes may have predated the appearance of fish during vertebrate evolution. In addition, vertebrate ECEL1 genes are seen to be more closely related to ECE1, ECE2, and KELL genes; whereas PHEX, NEP, and NEPL1 genes form a distinct subgroup of vertebrate M13 endopeptidase genes.
Conclusion
The results of the present study indicate that vertebrate ECEL1 genes and encoded proteins represent a distinct gene and protein family of ECE-like proteins which share key conserved sequences that have been reported for other ECE-like proteins (ECE1 and ECE2) studied previously. 7-10 ECEL1 has a unique property among these metalloendopeptidases in performing an essential role in the nervous control of respiration, although the natural substrate for ECEL1 has not been described. An association of the human and rat ECEL1 gene region with pulmonary and neural diseases has been previously identified (http://genome. ucsc.edu). 47 ECEL1 is encoded by a single gene among the vertebrate genomes studied, and is highly expressed in human and mouse neural tissues, particularly in the hypothalamus, pituitary, and sympathetic ganglion, and usually contains 17 coding exons on the negative strand. Human and other vertebrate ECEL1 genes contain a large CpG island within the promoter region. In addition, several transcription factor binding sites are also located within the ECEL1 gene promoter region, which may contribute to the high level of gene expression in neural tissues, such as the hypothalamus. For personal use only.
